CSNK1A1 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 3.067000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
6.171500E-02
Normal-vs-Stage2
3.162200E-01
Normal-vs-Stage3
9.495400E-01
Normal-vs-Stage4
1.484050E-01
Stage1-vs-Stage2
8.332200E-01
Stage1-vs-Stage3
2.982800E-01
Stage1-vs-Stage4
4.227200E-01
Stage2-vs-Stage3
2.211200E-01
Stage2-vs-Stage4
4.247400E-01
Stage3-vs-Stage4
1.607030E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
2.985600E-01
Normal-vs-AfricanAmerican
4.977200E-01
Normal-vs-Asian
4.931800E-01
Caucasian-vs-AfricanAmerican
8.821800E-01
Caucasian-vs-Asian
9.345000E-01
AfricanAmerican-vs-Asian
9.030400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
3.002600E-01
Normal-vs-Female
3.086000E-01
Male-vs-Female
4.210800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
2.878200E-01
Normal-vs-Age(41-60Yrs)
5.916300E-02
Normal-vs-Age(61-80Yrs)
5.025200E-01
Normal-vs-Age(81-100Yrs)
4.882600E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
1.886840E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
9.488000E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
9.223800E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
1.65728999999004E-05
Age(41-60Yrs)-vs-Age(81-100Yrs)
9.201200E-03
Age(61-80Yrs)-vs-Age(81-100Yrs)
7.897000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
5.584400E-01
Normal-vs-Daily Drinker
5.307200E-01
Normal-vs-Weekly Drinker
7.121800E-01
Normal-vs-Occasional Drinker
1.490190E-01
Normal-vs-Social Drinker
1.791620E-01
Non Drinker-vs-Daily Drinker
9.804000E-01
Non Drinker-vs-Weekly Drinker
6.599400E-01
Non Drinker-vs-Occasional Drinker
7.716000E-02
Non Drinker-vs-Social Drinker
2.929600E-01
Daily Drinker-vs-Weekly Drinker
6.469000E-01
Daily Drinker-vs-Occasional Drinker
8.942500E-02
Daily Drinker-vs-Social Drinker
3.019800E-01
Weekly Drinker-vs-Occasional Drinker
5.592000E-02
Weekly Drinker-vs-Social Drinker
1.608430E-01
Occasional Drinker-vs-Social Drinker
4.822400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
3.933900E-02
Normal-vs-Grade 2
7.555700E-04
Normal-vs-Grade 3
3.204800E-03
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
5.145600E-02
Grade 1-vs-Grade 3
1.283640E-01
Grade 1-vs-Grade 4
3.933900E-02
Grade 2-vs-Grade 3
9.126800E-01
Grade 2-vs-Grade 4
7.555700E-04
Grade 3-vs-Grade 4
3.204800E-03
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
5.483600E-01
Normal-vs-NonDiabetic
2.939400E-01
Diabetic-vs-NonDiabetic
1.239990E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
1.791630E-01
Normal-vs-NoPancreatitis
3.601800E-01
Pancreatitis-vs-NoPancreatitis
6.172800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
2.525600E-01
Normal-vs-N1
3.369200E-01
N0-vs-N1
8.217000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
1.339780E-01
Normal-vs-TP53-NonMutant
4.826000E-01
TP53-Mutant-vs-TP53-NonMutant
6.558500E-03
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
